Astrana Health, Inc. ASTH NASDAQ

Astrana Health, Inc. (ASTH) generated $-2.89M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $6K, free cash flow was $-2.88M.

Free cash flow margin was -0.3% of revenue. Cash conversion ratio was -0.44x, suggesting some earnings are non-cash.

The company returned $1.56M in dividends and $15.43M in share buybacks to shareholders during the quarter.

Criteria supported by this page:

• HEALTH (33/100, Fail) — weak cash flow raises concerns about debt servicing
• MOAT (24/100, Fail) — limited free cash flow weakens the competitive position
• INCOME (30/100) — Cash conversion ratio was -0.44x suggests some earnings are non-cash items

Overall SharesGrow Score: 56/100 with 3/7 criteria passed.